Illuminating Our Path Forward: Lessons from an Evolving Pandemic

1:00p.m.-5:00 p.m.

Welcome by George Q. Daley, MD, PhD, Dean of the Faculty of Medicine, Harvard University

Facilitating the Development and Availability of COVID-19 Vaccines, Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration

PANEL SESSION 1: SARS-CoV-2 Vaccination: Initial Success and Future Directions

1:50-2:45pm

Moderators: Galit Alter, PhD, Vice President of Immunology, Moderna and Dan Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center

Variants and cross-reactivity, William Hanage, PhD, Associate Professor of Epidemiology, Harvard T.H. Chan School of Public Health

Durability and waning immunity, Ai-ris Collier, MD, Assistant Professor of Obstetrics, Gynecology and Reproductive Biology, Beth Israel Deaconess Medical Center

Immunologic imprinting and boosting, Duane Wesemann, MD, PhD, Associate Professor of Medicine, Brigham and Women's Hospital

Vaccine global equity, vaccine hesitancy, Bisola Ojikutu, MD, MPH, Executive Director of the Boston Public Health Commission (BPHC)

BREAK

2:45-3:00pm

PANEL SESSION 2: COVID-19 Pathogenesis and Treatment

3:00-3:55pm

Moderators: Kate Fitzgerald, PhD, Professor and Vice Chair, Department of Medicine, UMASS Medical School and Manish Sagar, MD, Professor of Medicine, Boston University School of Medicine

Therapeutics, Jonathan Li, MD, MMSc, Associate Professor of Medicine, Brigham and Women's Hospital

Critical issues for kids, Lael Yonker, MD, Assistant Professor of Pediatrics, Massachusetts General Hospital

Long COVID, Bruce Levy, MD, Parker B. Francis Professor of Medicine, Brigham and Women's Hospital

What have we learned/or not about pandemics, Lindsey Baden, MD, Professor of Medicine, Brigham and Women's Hospital

PANEL SESSION 3: Preparing for SARS-CoV-2 Variants and Other Emerging Pathogens

3:55-4:50pm

Moderators: Amy Barczak, MD, Assistant Professor of Medicine, Massachusetts General Hospital and Jeremy Luban, MD, Professor, Program in Molecular Medicine, Biochemistry & Molecular Biotechnology, UMass Medical School

Domestic and international monitoring of variants, Katherine Siddle, PhD, Research Scientist, Broad Institute

Limits of SARS-CoV-2 evolution, Jonathan Abraham, MD, Assistant Professor of Microbiology

Monkeypox and other viruses, John Connor, PhD, Associate Professor of Microbiology, Boston University

Pathogens to focus on for the future, Jacob Lemieux, MD, Assistant Professor of Medicine, Massachusetts General Hospital

Closing Remarks

4:50-5pm

Reception 

5:00-6:30pm            

Joseph B. Martin Conference Center, Lobby and Elements Café